The company, which provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, reported year-on-year growth of 31 percent, compared to Q1 2010.
"First quarter 2011 was a landmark for ChromaDex as we had our largest quarter of revenue in the history of the Company," said Frank Jaksch, CEO and co-founder of ChromaDex.
"We are now poised to leverage our unique product and service offerings and, at the same time, capture rapidly accelerating revenue growth related to pTeroPure and other novel ingredients.
“We expect this strategy to further solidify ChromaDex as a leader in the natural products industry,” added Jaksch.
The company announced that the net loss attributable to common stockholders for the thirteen-week period ended April 2, 2011 was $1,156,385 as compared to a net income of $33,742 for the same period in 2010.
When the net loss is adjusted to exclude the effects of non-cash charges associated with share-based compensation expense, a "non-GAAP" presentation, the net loss for the first quarter 2011 is $419,366, and the loss per share for the first quarter 2011 is $0.01.
As of April 2, 2011, cash, cash equivalents, and marketable securities totaled over $2.8 million.